Cure My Disease

Don't miss your cure!

 Log in / Sign up

New prostate cancer shot tested as alternative to daily pills

NCT ID NCT07005154

Recruiting now Disease control Sponsor: Astellas Pharma Global Development, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new injectable form of a prostate cancer hormone therapy called ASP5541. It aims to see if this injection, given every 12 weeks, works as well or better than the standard daily pill version and if it causes fewer side effects. The trial will enroll about 218 men with advanced prostate cancer that has spread to other parts of the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Carolina Urologic Research Center

    RECRUITING

    Myrtle Beach, South Carolina, 29572, United States

  • DE49004

    RECRUITING

    Nürtingen, Baden-Wurttemberg, Germany

  • H. Lee Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • Harasanshin Hospital

    RECRUITING

    Fukuoka, Japan

  • KR82008

    RECRUITING

    Gwangju, South Korea

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa, Chiba, Japan

  • New Mexico Oncology Hematology Consultants

    RECRUITING

    Albuquerque, New Mexico, 87109, United States

  • Nippon Medical School Hospital

    RECRUITING

    Bunkyo-ku, Tokyo, Japan

  • Osaka International Cancer Institute

    RECRUITING

    Osaka, Japan

  • PanOncology Trials

    RECRUITING

    San Juan, 00935, Puerto Rico

  • Shizuoka Cancer Center

    RECRUITING

    Sunto-gun, Shizuoka, Japan

  • The Cancer Institute Hospital of JFCR

    RECRUITING

    Koto-ku, Tokyo, Japan

Conditions

Explore the condition pages connected to this study.

METASTATIC CASTRATION RESISTANT PROSTATE CANCER METASTATIC HORMONE SENSITIVE PROSTATE CANCER PROSTATE CANCER